Compare MLGO & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLGO | INCR |
|---|---|---|
| Founded | 2018 | 1994 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.5M | 79.3M |
| IPO Year | N/A | N/A |
| Metric | MLGO | INCR |
|---|---|---|
| Price | $5.69 | $1.13 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 98.5K | 53.9K |
| Earning Date | 12-16-2025 | 02-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 4.04 | N/A |
| Revenue | $61,302,336.00 | ★ $72,158,312.00 |
| Revenue This Year | N/A | $69.54 |
| Revenue Next Year | N/A | $41.75 |
| P/E Ratio | $1.41 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.66 | $1.02 |
| 52 Week High | $972.00 | $1.79 |
| Indicator | MLGO | INCR |
|---|---|---|
| Relative Strength Index (RSI) | 33.57 | 33.31 |
| Support Level | $6.44 | $1.35 |
| Resistance Level | $7.05 | $1.51 |
| Average True Range (ATR) | 0.44 | 0.07 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 1.14 | 21.44 |
MicroAlgo Inc is divided into two segments: Central processing algorithm services & Intelligent chips and services. The majority is from the Central Processing Algorithm Services. which refers to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.